Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01696 SISRAM MED
RT Nominal unchange3.480 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
USD(K$)
%Chg
(Final to Final)
2022/12
USD(K$)
2021/12
USD(K$)
2020/12
USD(K$)
2019/12
USD(K$)
Investment Properties0--0000
Property, plant, equip. & others22,81135.401%16,84714,56512,8135,328
Land & other Lease Assets40,09813.415%35,35530,89233,3488,921
Intangible Assets262,98468.072%156,471162,407164,464169,813
Interests in Asso. & JCEs6,156-0.324%6,1761,3851730
Other Non-current Assets24,104-73.273%90,18723,28315,85812,055

356,15316.758%305,036232,532226,656196,117
Current Assets
2023/12 - Final
USD(K$)
%Chg
(Final to Final)
2022/12
USD(K$)
2021/12
USD(K$)
2020/12
USD(K$)
2019/12
USD(K$)
Inventories80,5507.802%74,72064,23637,19133,018
Trade Receivables83,4563.829%80,37869,87546,50149,474
Cash & Bank Balances70,601-13.424%81,548153,062116,527107,792
Other Current Assets22,74263.388%13,91910,4274,9316,431
Assets Held for Sale0--0000

257,3492.707%250,565297,600205,150196,715
Current Liabilities
2023/12 - Final
USD(K$)
%Chg
(Final to Final)
2022/12
USD(K$)
2021/12
USD(K$)
2020/12
USD(K$)
2019/12
USD(K$)
Trade Payables7,998-40.022%13,33513,0189,44411,992
S-T Debt & Leases9,1385.972%8,62310,3864,3355,331
Other Current Liabilities71,11422.258%58,16760,15241,01422,095
Liab asso w/ Assets Held for Sale0--0000

88,25010.140%80,12583,55654,79339,418
Net Current Assets169,099-0.787%170,440214,044150,357157,297
Total Assets Less Current Liabilities525,25210.469%475,476446,576377,013353,414
Non-current Liabilities
2023/12 - Final
USD(K$)
%Chg
(Final to Final)
2022/12
USD(K$)
2021/12
USD(K$)
2020/12
USD(K$)
2019/12
USD(K$)
L-T Debt & Leases35,5448.637%32,71831,23532,7286,871
Other Non-current Liabilities20,18391.617%10,53311,71612,39620,973

55,72728.846%43,25142,95145,12427,844
Capital and Reserves
2023/12 - Final
USD(K$)
%Chg
(Final to Final)
2022/12
USD(K$)
2021/12
USD(K$)
2020/12
USD(K$)
2019/12
USD(K$)
  Share Capital1,3340.225%1,3311,3281,2541,254
  Reserves450,9774.990%429,541400,854330,635324,316
  Others0--0000
Shareholders' Funds452,3114.976%430,872402,182331,889325,570
Non-controlling Interests17,2141172.284%1,3531,44300
Others0--0000

469,5258.630%432,225403,625331,889325,570
Commitments and Contingent Liabilities
2023/12 - Final
USD(K$)
%Chg
(Final to Final)
2022/12
USD(K$)
2021/12
USD(K$)
2020/12
USD(K$)
2019/12
USD(K$)
Commitments----0000
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 19/07/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders ($)USD 31,499,000
%Change-21.586%
EPS / (LPS)USD 0.067
NBV Per Share ($)USD 0.966
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.